Cancer is often viewed as a deadly condition, and for many people, the fear of dying is what hits hardest. Its unpredictable behavior, along with the chance it could return—even after recovery—causes deep anxiety, especially among survivors.
The fear around cancer isn’t simple. It’s shaped by how serious people think it is, how it can disrupt their lives, and how it affects them emotionally and socially. That’s why dealing with it isn’t just about treatment—it also takes clear information, mental health support, and scientific tools. And science is doing its part.
According to Live Science, a patient’s chances of surviving cancer usually drop the longer the disease goes undetected—especially after it spreads to other parts of the body. But the gene mutations that cause tumors usually start decades before a person gets diagnosed.
Now, new research has found something big: cancer-related DNA changes can be spotted in blood three years before doctors even give a diagnosis. This study, published on May 22 in Cancer Discovery Diagnosis and funded partly by the National Institutes of Health, opens the door to early detection.
Dr. Yuxuan Wang, an oncologist at Johns Hopkins University, along with her team, aimed to find out if signs of cancer could be found in blood plasma long before any symptoms show up. If cancer can be detected three years in advance, there’s a window for early treatment—when the disease is likely to be smaller, easier to treat, and even curable.
Dr. Wang said the researchers were surprised to see cancer-causing DNA mutations show up so early in the blood.
To dig deeper, the team used blood samples from an older research project—the ARIC study—which originally looked into heart disease risks. They used extremely accurate sequencing tools to test blood from 26 people who developed cancer within six months of giving the sample, and 26 people who didn’t develop cancer.
At the time of testing, eight of the 52 people showed positive results using a multi-cancer early detection (MCED) test. All eight were diagnosed with cancer within four months after their blood was taken.
In six of those eight cases, older blood samples—collected more than three years before diagnosis—were also available. And in four of them, the researchers found tumor-linked mutations even in those earlier samples.
“This work shows what early detection tests like MCED can do and what kind of accuracy they need to succeed,” said Bert Vogelstein, Professor of Oncology and co-director at the Ludwig Center, Johns Hopkins.
Another researcher at the same institute, Nicholas Papadopoulos, added, “We now need to figure out how to properly follow up with patients after a positive result. Catching cancer years earlier could really shift the outcomes in patients’ favor.”
